Results for tag: "Mitochondrial Disease Drug"

The Mitochondrial Disease Drug market is a subset of the Central Nervous System Drugs market. Mitochondrial Disease Drugs are used to treat a variety of conditions, including mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). These drugs are designed to improve the function of mitochondria, the organelles responsible for energy production in cells. Mitochondrial Disease Drugs are typically administered orally or intravenously, and may be used in combination with other therapies. The Mitochondrial Disease Drug market is highly competitive, with a number of companies offering products for the treatment of mitochondrial diseases. These companies include Genzyme Corporation, BioMarin Pharmaceuticals, and Sanofi Genzyme. Other companies in the market include Pfizer, Novartis, and Merck. Show Less Read more